- US11767365utility2023BCMA Antibodies and Use of Same to Treat Cancer and Immunological Disorders0 cites
- US11730822utility2023Process for the Preparation of Glucuronide Drug-linkers and Intermediates Thereof0 cites
- US11666572utility2023Treatment of HER2 Positive Cancers0 cites
- US11667696utility2023Selective Reduction of Proteins0 cites
- US11638762utility2023Targeted Delivery of Nicotinamide Adenine Dinucleotide Salvage Pathway Inhibitors0 cites
- US11634503utility2023Antibody Drug Conjugates (ADC) That Bind to 158P1D7 Proteins0 cites
- US11617798utility2023Anti-cd228 Antibodies and Antibody-drug Conjugates0 cites
- US11612666utility2023Process for the Preparation of Drug Linker Compounds0 cites
- US11559558utility2023Weekly Dosing Regimens for Anti-cd30 Vc-pab-mmae Antibody Drug-conjugates0 cites
- US11559582utility2023Antibody Drug Conjugates (ADC) That Bind to 191P4D12 Proteins0 cites
- US11541128utility2023Multi-drug Antibody Drug Conjugates0 cites
← PreviousPage 2 of 2